Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A versatile and tunable coating strategy allows control of nanocrystal delivery to cell types in the liver.

Cormode DP, Skajaa GO, Delshad A, Parker N, Jarzyna PA, Calcagno C, Galper MW, Skajaa T, Briley-Saebo KC, Bell HM, Gordon RE, Fayad ZA, Woo SL, Mulder WJ.

Bioconjug Chem. 2011 Mar 16;22(3):353-61. doi: 10.1021/bc1003179. Epub 2011 Mar 1.

2.

Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging.

Schweiger C, Pietzonka C, Heverhagen J, Kissel T.

Int J Pharm. 2011 Apr 15;408(1-2):130-7. doi: 10.1016/j.ijpharm.2010.12.046. Epub 2011 Feb 18.

PMID:
21315813
3.

SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.

Lee CM, Jeong HJ, Kim SL, Kim EM, Kim DW, Lim ST, Jang KY, Jeong YY, Nah JW, Sohn MH.

Int J Pharm. 2009 Apr 17;371(1-2):163-9. doi: 10.1016/j.ijpharm.2008.12.021. Epub 2008 Dec 24.

PMID:
19138733
4.

Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.

Parveen S, Sahoo SK.

Eur J Pharmacol. 2011 Nov 30;670(2-3):372-83. doi: 10.1016/j.ejphar.2011.09.023. Epub 2011 Sep 21. Erratum in: Eur J Pharmacol. 2014 Mar 15;727:186.

PMID:
21951969
5.

Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture.

Yu M, Huang S, Yu KJ, Clyne AM.

Int J Mol Sci. 2012;13(5):5554-70. doi: 10.3390/ijms13055554. Epub 2012 May 9.

6.

Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.

Chen Z, Yu D, Liu C, Yang X, Zhang N, Ma C, Song J, Lu Z.

J Drug Target. 2011 Sep;19(8):657-65. doi: 10.3109/1061186X.2010.531727. Epub 2010 Nov 23.

PMID:
21091273
7.

One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.

Dai L, Liu Y, Wang Z, Guo F, Shi D, Zhang B.

Mater Sci Eng C Mater Biol Appl. 2014 Aug 1;41:161-7. doi: 10.1016/j.msec.2014.04.041. Epub 2014 Apr 28.

PMID:
24907749
8.

Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.

Vila A, Gill H, McCallion O, Alonso MJ.

J Control Release. 2004 Aug 11;98(2):231-44.

PMID:
15262415
9.

PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo.

Sun C, Du K, Fang C, Bhattarai N, Veiseh O, Kievit F, Stephen Z, Lee D, Ellenbogen RG, Ratner B, Zhang M.

ACS Nano. 2010 Apr 27;4(4):2402-10. doi: 10.1021/nn100190v.

10.

Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles.

Huang J, Bu L, Xie J, Chen K, Cheng Z, Li X, Chen X.

ACS Nano. 2010 Dec 28;4(12):7151-60. doi: 10.1021/nn101643u. Epub 2010 Nov 2.

11.

Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.

Chen YC, Chang WH, Wang SJ, Hsieh WY.

J Biomater Sci Polym Ed. 2012;23(15):1903-22. doi: 10.1163/092050611X598329. Epub 2012 May 8.

PMID:
22024467
12.

Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles.

Cole AJ, David AE, Wang J, Galbán CJ, Yang VC.

Biomaterials. 2011 Sep;32(26):6291-301. doi: 10.1016/j.biomaterials.2011.05.024.

13.

Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines.

Zhu XM, Wang YX, Leung KC, Lee SF, Zhao F, Wang DW, Lai JM, Wan C, Cheng CH, Ahuja AT.

Int J Nanomedicine. 2012;7:953-64. doi: 10.2147/IJN.S28316. Epub 2012 Feb 21.

14.

Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent.

Prashant C, Dipak M, Yang CT, Chuang KH, Jun D, Feng SS.

Biomaterials. 2010 Jul;31(21):5588-97. doi: 10.1016/j.biomaterials.2010.03.070.

PMID:
20434210
15.

Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging.

Jie LY, Cai LL, Wang LJ, Ying XY, Yu RS, Zhang MM, Du YZ.

Int J Nanomedicine. 2012;7:3981-9. doi: 10.2147/IJN.S33593. Epub 2012 Jul 24.

16.

Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.

Yang X, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, Matson VZ, Steeber DA, Gong S.

ACS Nano. 2010 Nov 23;4(11):6805-17. doi: 10.1021/nn101670k. Epub 2010 Oct 19.

PMID:
20958084
17.

Single-Step Assembly of Multimodal Imaging Nanocarriers: MRI and Long-Wavelength Fluorescence Imaging.

Pinkerton NM, Gindy ME, Calero-DdelC VL, Wolfson T, Pagels RF, Adler D, Gao D, Li S, Wang R, Zevon M, Yao N, Pacheco C, Therien MJ, Rinaldi C, Sinko PJ, Prud'homme RK.

Adv Healthc Mater. 2015 Jun 24;4(9):1376-85. doi: 10.1002/adhm.201400766. Epub 2015 Apr 30.

18.

Characterization and in vitro cellular uptake of PEG coated iron oxide nanoparticles as MRI contrast agent.

Chen YJ, Tao J, Xiong F, Zhu JB, Gu N, Geng KK.

Pharmazie. 2010 Jul;65(7):481-6.

PMID:
20662315
19.
20.

The One Year Fate of Iron Oxide Coated Gold Nanoparticles in Mice.

Kolosnjaj-Tabi J, Javed Y, Lartigue L, Volatron J, Elgrabli D, Marangon I, Pugliese G, Caron B, Figuerola A, Luciani N, Pellegrino T, Alloyeau D, Gazeau F.

ACS Nano. 2015 Aug 25;9(8):7925-39. doi: 10.1021/acsnano.5b00042. Epub 2015 Jul 21.

PMID:
26168364

Supplemental Content

Support Center